Peer-influenced content. Sources you trust. No registration required. This is HCN.

MDLinxHealth Privacy Laws and Potential Risks to Patients After 23andMe Data Breach

Genetic Data Breach at 23andMe: A Wake-Up Call for Health Privacy Laws

In the evolving landscape of digital health data, the recent data breach at 23andMe has raised significant concerns about health privacy laws and the potential risks to patients. This incident underscores the vulnerability of genetic data and the implications for privacy laws.

Key Points

  • An unknown party hacked into 23andMe and stole millions of data points from specific users.
  • The hacker may have been able to access certain accounts of users who used the same password for 23andMe as they did for other sites.
  • Experts say the breach isn’t a HIPAA violation, but other health privacy laws may apply.
  • The leaked data contained millions of data points from Ashkenazi Jewish 23andMe users, as well as users of Chinese heritage.
  • It is unclear whether these individuals were specifically targeted.

“There is also a possibility that the attacker might sell patients’ health data to third-party entities. These entities could include insurance companies, pharmaceutical firms, or any organization interested in utilizing information.”
— Joseph Harisson, CEO, IT Companies Network

More on Genetic Testing

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form